The Procter & Gamble Company Q4 2025 Earnings Recap

Procter & Gamble demonstrated solid resilience in fiscal year 2025, achieving a 2% organic sales growth and a 4% increase in core EPS amid challenging market conditions. Strategic leadership transitions position the company for continued growth.

Key Takeaways

• Organic sales grew 2% for FY25, driven evenly by volume and price/mix contributions, with nine of ten product categories experiencing growth.
• Core EPS increased to $6.83, reflecting efficient cost management and a focus on productivity improvements despite a 40 basis point decline in core gross margin.
• The company returned $16 billion to shareholders, including nearly $10 billion in dividends and $6.5 billion through share repurchases, remaining consistent with prior guidance.